This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Cornell University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations of Xi Wang in Therapeutic Delivery Systems
Introduction
Xi Wang is an accomplished inventor based in Ithaca, NY (US). She has made significant contributions to the field of biocompatible polymers and their applications in therapeutic delivery systems. Her innovative work focuses on creating fibers that can be utilized in medical treatments, particularly for diabetes.
Latest Patents
Xi Wang holds a patent for "Fibers of polymers that have a backbone including a positively charged component of a zwitterionic moiety, and their use in implantable therapeutic delivery systems." This patent describes fibers with diameters ranging from 1 nm to 10,000 nm, made from one or more biocompatible polymers. The polymers feature a backbone that includes a positively charged component derived from a zwitterionic moiety. The patent also details an implantable therapeutic delivery system that comprises a porous housing formed from these fibers, which contains a preparation of cells that release therapeutic agents. This system is particularly useful in the treatment of diabetes.
Career Highlights
Xi Wang is affiliated with Cornell University, where she continues her research and development in the field of polymer science and therapeutic applications. Her work has garnered attention for its potential impact on medical treatments and patient care.
Collaborations
Some of her notable coworkers include Minglin Ma and James A. Flanders, who have collaborated with her on various research projects.
Conclusion
Xi Wang's innovative contributions to the field of therapeutic delivery systems highlight her role as a leading inventor in biocompatible polymers. Her work not only advances scientific knowledge but also holds promise for improving treatment options for patients with diabetes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
